Subtype-associated metabolite differences in the temporal lobe in schizophrenia detected by proton magnetic resonance spectroscopy

Psychiatry Research - Neuroimaging

Volumn 92, Issue 1, 1999, Pages 45-56

  Fukuzako, Hiroshi ^a   Kodama, Satoshi ^a   Fukuzako, Tsuyoshi ^a   Yamada, Koichiro ^a   Doi, Wataru ^a   Sato, Daisuke ^a   Takigawa, Morikuni ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Creatine; Disorganized subtype; Inositol; N Acetylaspartate

Indexed keywords

CREATINE; INOSITOL; N ACETYLASPARTIC ACID; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRAIN METABOLISM; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEURORADIOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOSIS; SCHIZOPHRENIA; TEMPORAL LOBE;

ASPARTIC ACID; BRAIN MAPPING; CHOLINE; CREATINE; DOMINANCE, CEREBRAL; ENERGY METABOLISM; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; SCHIZOPHRENIA; SCHIZOPHRENIA, DISORGANIZED; SCHIZOPHRENIA, PARANOID; TEMPORAL LOBE;

EID: 0032759290     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(99)00035-9     Document Type: Article

References (62)

1. Altshuler L.L., Conrad A., Kovelman J.A., Scheibel A. Hippocampal pyramidal cell orientation in schizophrenia: a controlled neurohistologic study of the Yakovlev Collection. Archives of General Psychiatry. 44:1987;1094-1098.
2. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised, 1987;American Psychiatric Press, Washington, DC.
3. Andreasen N.C., O'Leary D.S., Flaum M., Nopoulos P., Watkins G.L., Ponto L.L.B., Hichwa R.D. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients. Lancet. 349:1997;1730-1734.
4. Bartha R., Al-Semaan Y.M., Williamson P.C., Drost D.J., Malla A.K., Carr T.J., Canaran G., Neufeld R.W.J. A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients. Biological Psychiatry. 45:1999;1403-1411.
5. Bertolino A., Callicott J.H., Elman I., Mattay V.S., Tedeschi G., Frank J.A., Breier A., Weinberger D.R. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biological Psychiatry. 43:1998;641-648.
6. Bertolino A., Kumra S., Callicott J.H., Mattay V.S., Lestz B.S., Jacobsen L., Barnett I.S., Duyn J.H., Frank J.A., Rapoport J.L., Weinberger D.R. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. American Journal of Psychiatry. 155:1998;1376-1383.
7. 31P-MRS of the schizophrenic brain in vivo. Journal of Computer Assisted Tomography. 23:1999;272-275.
8. Bogerts B., Meertz E., Schönfeldt-Bausch R. Basal ganglia and limbic system pathology in schizophrenia: a morphometric study of brain volume and shrinkage. Archives of General Psychiatry. 42:1985;784-791.
9. Brown R., Colter N., Corsellis J.A.N., Crow T.J., Frith C.D., Jagoe R., Johnstone E.C., Marsh L. Postmortem evidence of structural brain changes in schizophrenia: differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Archives of General Psychiatry. 43:1986;36-42.
10. 1H-magnetic resonance spectroscopy in schizophrenia. Biological Psychiatry. 36:1994;792-800.
11. Callicott J.H., Egan M.F., Bertolino A., Mattay V.S., Langheim F.J.P., Frank J.A., Weinberger D.R. Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype. Biological Psychiatry. 44:1998;941-950.
12. Cecil K.M., Lenkinski R.E., Gur R.E., Gur R.C. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia. Neuropsychopharmacology. 20:1999;131-140.
13. Choe B.-Y., Suh T.-S., Shinn K.-S., Lee C.-W., Lee C., Paik I.-H. Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy. Investigative Radiology. 31:1996;345-352.
14. Cowell P.E., Kostianovsky D.J., Gur R.C., Turetsky B.I., Gur R.E. Sex differences in neuroanatomical and clinical correlations in schizophrenia. American Journal of Psychiatry. 153:1996;799-805.
15. Deicken R.F., Ling Z., Fein G., Weiner M.W. Decreased regional neuronal density in schizophrenia. Biological Psychiatry. 42:1997;123S-124S.
16. Deicken R.F., Zhou L., Schuff N., Fein G., Weiner M.W. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy. Biological Psychiatry. 43:1998;483-488.
17. Egan M.F., Weinberger D.R. Neurobiology of schizophrenia. Current Opinion in Neurobiology. 7:1997;701-707.
18. Eluri R., Paul C., Roemer R., Boyko O. Single-voxel proton magnetic resonance spectroscopy of the pons and cerebellum in patients with schizophrenia: a preliminary study. Psychiatry Research: Neuroimaging. 84:1998;17-26.
19. Falkai P., Bogerts B., Rozumek M. Limbic pathology in schizophrenia: the entorhinal region - a morphometric study. Biological Psychiatry. 24:1988;515-521.
20. Fenton W.S., McGlashan T.H. Natural history of schizophrenia subtypes. I. Longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia. Archives of General Psychiatry. 48:1991;969-986.
21. Friston K.J., Liddle P.F., Frith C.D., Hirsch S.R., Frackowiak R.S.J. The left medial temporal region and schizophrenia: a PET study. Brain. 115:1992;367-382.
22. Fukuzako H., Takeuchi K., Hokazono Y., Fukuzako T., Yamada K., Hashiguchi T., Obo Y., Ueyama K., Takigawa M., Fujimoto T. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report. Psychiatry Research: Neuroimaging. 61:1995;193-200.
23. Fukuzako H., Fukuzako T., Hashiguchi T., Hokazono Y., Takeuchi K., Hirakawa K., Ueyama K., Takigawa M., Kajiya Y., Nakajo M., Fujimoto T. Reduction in hippocampal formation volume is caused mainly by its shortening in chronic schizophrenia: assessment by MRI. Biological Psychiatry. 39:1996;938-945.
24. Fukuzako H., Yamada K., Kodama S., Yonezawa T., Fukuzako T., Takenouchi K., Kajiya Y., Nakajo M., Takigawa M. Hippocampal volume asymmetry and age at illness onset in males with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 247:1997;248-251.
25. Guerguerian R., Lewine R.R. Brain torque and sex differences in schizophrenia. Schizophrenia Research. 30:1998;175-181.
26. Häfner H., Mauer K., Löffler W., an der Heiden W., Munk-Jørgensen P., Hambrecht M., Riecher-Rössler A. The ABC schizophrenia study: a preliminary overview of the results. Social Psychiatry and Psychiatric Epidemiology. 33:1998;380-386.
27. Heimberg C., Komoroski R.A., Lawson W.B., Cardwell D., Karson C.N. Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect. Psychiatry Research: Neuroimaging. 83:1998;105-115.
28. Itoh H. Pharmacotherapy of schizophrenia: its present status and controversial points [in Japanese]. Seishin Igaku. 27:1985;521-530.
29. Jacob H., Beckmann H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. Journal of Neural Transmission. 65:1986;303-326.
30. Jeste D.V., Lohr J.B. Hippocampal pathologic findings in schizophrenia: a morphometric study. Archives of General Psychiatry. 46:1989;1019-1024.
31. Kay S.R., Opler L.A. Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCI-PANSS). 1988;Albert Einstein College of Medicine, New York.
32. Kay S.R., Opler L.A., Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Rating Manual. 1986;Albert Einstein College of Medicine, New York.
33. Kegeles L.S., Humaran T.J., Mann J.J. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy. Biological Psychiatry. 44:1998;382-398.
34. Lawrie S.M., Abukmeil S.S. Brain abnormality in schizophrenia: a systematic and quantitative review of volumetric magnetic resonance imaging studies. British Journal of Psychiatry. 172:1998;110-120.
35. Lewine R. Schizophrenia: an amotivational syndrome in men. Canadian Journal of Psychiatry. 30:1985;316-318.
36. Lewine R.R.J., Huddgins P., Brown F., Caudle J., Risch S.C. Differences in qualitative brain morphology findings in schizophrenia, major depression, bipolar disorder and normal volunteers. Schizophrenia Research. 15:1995;253-259.
37. Lieberman J., Jody D., Geisler S., Alvir J., Loebel A., Szymanski S., Woerner M., Borenstein M. Time course and biologic correlates of treatment response in first-episode schizophrenia. Archives of General Psychiatry. 50:1993;369-376.
38. Lim K.O., Adalsteinsson E., Spielman D., Sullivan E.V., Rosenbloom M.J., Pfefferbaum A. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Archives of General Psychiatry. 55:1998;346-352.
39. Maier M., Ron M.A., Barker G.J., Tofts P.S. Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia. Psychological Medicine. 25:1995;1201-1209.
40. McCarley R.W., Wible C.G., Frumin M., Hirayasu Y., Levitt J.J., Fischer I.A., Shenton M.E. MRI anatomy of schizophrenia. Biological Psychiatry. 45:1999;1099-1119.
41. McClure R.J., Keshavan M.S., Pettegrew J.W. Chemical and physiologic brain imaging in schizophrenia. Psychiatric Clinics of North America. 21:1998;93-122.
42. 1H MRS) of the hippocampal formation in schizophrenia: a pilot study. British Journal of Psychiatry. 165:1994;481-485.
43. Nelson M.D., Saykin A.J., Flashman L.A., Riordan H.J. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging. Archives of General Psychiatry. 55:1998;433-440.
44. Nopoulos P., Flaum M., Andreasen N.C. Sex differences in brain morphology in schizophrenia. American Journal of Psychiatry. 154:1997;1648-1654.
45. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 9:1971;97-113.
46. Renshaw P.F., Yurgelun-Todd D.A., Tohen M., Gruber S.A., Cohen B.M. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. American Journal of Psychiatry. 152:1995;444-446.
47. Salibi N., Brown M.A. Clinical MR Spectroscopy. 1998;134-137 Wiley-Liss, New York.
48. Schachter S.C., Ransil B.J., Geschwind N. Associations of handedness with hair color and learning disabilities. Neuropsychologia. 25:1987;269-276.
49. 123I] iodobenzamide single photon emission computed tomography study. Psychiatry Research: Neuroimaging. 75:1997;115-123.
50. Schultz S.K., Miller D.D., Oliver S.E., Arndt S., Flaum M., Andreasen N.C. The life course of schizophrenia: age and symptom dimensions. Schizophrenia Research. 23:1997;15-23.
51. Seeman M.V. Current outcome in schizophrenia: women vs. men. Acta Psychiatrica Scandinavica. 73:1986;609-617.
52. Sharma R., Venkatasubramanian P.N., Bárány M., Davis J.M. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophrenia Research. 8:1992;43-49.
53. Shioiri T., Someya T., Murashita J., Kato T., Hamakawa H., Fujii K., Inubushi T. Multiple regression analysis of relationship between frontal lobe phosphorus metabolism and clinical symptoms in patients with schizophrenia. Psychiatry Research: Neuroimaging. 76:1997;113-122.
54. Spitzer R.L., Williams J.B., Gibbon M. Instruction Manual for the Structured Clinical Interview for DSM-III-R (SCID). 1987;New York State Psychiatric Institute, New York.
55. Swahn C.-G. Determination of N-acetylaspartic acid in human cerebrospinal fluid by gas chromatography-mass spectrometry. Journal of Neurochemistry. 54:1990;1584-1588.
56. Szymanski S., Lieberman J.A., Alvir J.M., Mayerhoff D., Loebel A., Geisler S., Chakos M., Koreen A., Jody D., Kane J., Woerner M., Cooper T. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. American Journal of Psychiatry. 152:1995;698-703.
57. Takeuchi K., Takigawa M., Fukuzako H., Hokazono Y., Hirakawa K., Fukuzako T., Ueyama K., Fujimoto T., Matsumoto K. Correlation of third ventricular enlargement and EEG slow wave activity in schizophrenic patients. Psychiatry Research: Neuroimaging. 55:1994;1-11.
58. Tamminga C.A. Gender and schizophrenia. Journal of Clinical Psychiatry. 58S:1997;33-37.
59. Tamminga C.A., Thaker G.K., Buchanan R., Kirkpatrick B., Alphs L.D., Chase T.N., Carpenter W.T. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Archives of General Psychiatry. 49:1992;522-530.
60. Thomas M.A., Ke Y., Levitt J., Caplan R., Curran J., Asarnow R., McCracken J. Preliminary study of frontal H-1 MR spectroscopy in childhood-onset schizophrenia. Journal of Magnetic Resonance Imaging. 8:1998;841-846.
61. Yurgelun-Todd D.A., Renshaw P.F., Gruber S.A., Waternaux C., Cohen B.M. Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls. Schizophrenia Research. 19:1996;55-59.
62. Zigler E., Glick M., Marsh A. Premorbid social competence and outcome among schizophrenic and non-schizophrenic patients. Journal of Nervous and Mental Disease. 167:1978;478-483.